National Cancer Genetics MDT

The National Cancer Genetics MDT (UKCGG National CGM) is a collaboration between the CanGene-CanVar Programme and the UK Cancer Genetics Group (UKCGG), which aims to create a regular national forum to discuss complex cancer genetics cases, improve patient management and expand clinical knowledge.

For patient confidentiality and clinical governance, meeting attendees will be required to register for the meeting in advance and are required to work within the NHS in the area of cancer genetics.

National Cancer Genetics MDT Objectives:

Creation of a national multidisciplinary professional network and regular forum to discuss and advise on complex cancer genetics cases.
Improve outcomes and consistency of care for patients by facilitating multidisciplinary discussion.
Identify areas in which national guidelines are required or need updating.
Improve training and education in clinical cancer genetics.
Facilitate relevant publications in peer-reviewed journals based on cases discussed, best practice guidelines and the value of a national forum for clinicians and patients.

Next Meeting

18 March

2021

Agenda

CanRisk - with guest speaker Professor Antonis Antoniou

If you are a member of the British Society for Genetic Medicine (BSGM) and are interested in becoming part of the UKCGG, please click here for more information.

Please see our UKCGG National CGM resources below for an up-to-date list of meeting summaries, educational tools, references and web-based links.

Register to attend the next MDT

You must register in advance for this meeting

For patient confidentiality and clinical governance, meeting attendees will be required to register for the meeting in advance and are required to work within the NHS in the area of cancer genetics - please ensure that you register with your full name and NHS or academic email

CanRisk with guest speaker Professor Antonis Antoniou
Thursday March 18th 12.30-13.45

Please register via the following link:

https://the-icr.zoom.us/meeting/register/u5wodOqoqj4sGdEb9qwTfyGVRqD-_AeJPf_V

After registering, you will receive a confirmation email containing information about joining the meeting.

National Cancer Genetics MDT Format

Bi-monthly 60-75 minute MDT via Microsoft Teams (with the possibility to increase this to monthly)

Current time slot: 12:30-13:45, 3rd Thursday of the month, starting 15th October (to review future dates and alter if required)

Ground rules for the meeting will be circulated to all attendees

MDT to alternate between:

Expert topic - Short presentation by an invited expert and then discussion of 3-4 cases relevant to that specific topic
Mixed cases - Approx. 6 cases to include a mixture of cases where a clinical decision is required and "known" cases highlighting a specific learning point

Cases to be submitted in advance of the meeting using a set slide format clearly stating clinical questions or learning points

Cases which involve variant classification should be discussed in Can-VIG

Cases which involve significant ethical issues/debates should be discussed in GenETHICS

There will be nominated session Chair (Consultant in Cancer Genetics/Senior GC) which can be rotated through different centres

CPD accreditation (RCP) if possible

The Chair will select the cases for discussion and run the meeting with the help of an additional person to minute discussions and agreed actions

At least one representative from each centre should attend